Effect of inhaled nitric oxide on cardiovascular response to catecholamine in heart failure

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 6 SUPPL. 2, 2000, Pages

  Natori, Shunsuke ^a   Hasebe, Naoyuki ^a   Jin, Yin Tie ^a   Matsusaka, Tomoyuki ^a   Ohta, Takafumi ^a   Tsuji, Shiro ^a   Morihira, Masahiko ^a   Nakamura, Hideki ^a   Ido, Akira ^a   Matsuhashi, Hironobu ^a   Kikuchi, Kenjiro ^a   Motomura, Shigeru ^a   Toyo Oka, Teruhiko ^a   Hirata, Yasunobu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Cardiac function; Heart failure; Inhaled nitric oxide; Left ventricular preload; Pulmonary vasodilation

Indexed keywords

ISOPRENALINE; NITRIC OXIDE; NORADRENALIN; PROCAINAMIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CARDIOVASCULAR RESPONSE; CATECHOLAMINE RELEASE; CONFERENCE PAPER; CONTROLLED STUDY; DOG; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PRELOAD; INOTROPISM; LUNG VASCULAR RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0034480771     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200000006-00012     Document Type: Conference Paper

References (33)

1. The L-arginine-nitric oxide pathway
2. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
3. Paracrine coronary endothelial control of left ventricular function in humans
4. Nitric oxide synthases and cardiovascular signaling
5. Role of nitric oxide in the regulation of myocardial function
6. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation
7. Nitric oxide - A new endogenous immunomodulator
8. Biotransformation of nitric oxide
9. Control of coronary vascular tone by nitric oxide
10. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation
11. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
12. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn
13. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
14. Inhaled nitric oxide in congenital heart disease
15. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension
16. Inhaled nitric oxide improves lung allograft function after prolonged storage
17. Inhaled nitric oxide for the adult respiratory distress syndrome
18. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
19. Nitric oxide attenuates cardiac myocyte contraction
20. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
21. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction
22. Effects of a nitric oxide synthase inhibitor in humans with septic shock
23. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
24. Sepsis and nitric oxide
25. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog
26. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction
27. Hemodynamic effects of inhaled nitric oxide in heart failure
28. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure
29. Inhaled nitric oxide in cardiac failure: Vascular versus ventricular effects
30. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure
31. Externalization of beta-adrenergic receptors promoted by myocardial ischemia
32. Relationship between beta-adrenergic receptor numbers and physiological responses during experimental canine myocardial ischemia
33. Dual sensitization of the adrenergic system in early myocardial ischemia: Independent regulation of the beta-adrenergic receptors and the adenylyl cyclase